CARLSBAD, Calif.--(BUSINESS WIRE)--Brendan Technologies, Inc. (OTCBB: BDTE), an innovative analytical software company, said that Dr. John Dunn, founder and chief executive officer, will be hosting a half-day seminar entitled, Qualitative and Quantitative Tests for Neutralizing Antibodies, at the 8th Annual Immunogenicity for Biotherapeutics Conference in San Diego on May 8, 2007. This is the largest immunogenicity conference tracking assay development and validation, data analysis and regulatory considerations.
